Study

Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis. – Cost Effective Supplements

Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/20070280


Conclusion of this study

EPs-7630 is effective in acute bronchitis outside the strict indication for antibiotics in 6-18 years old patients, with a dose of 60 mg or 90 mg daily offering the best benefit/risk ratio. EPs-7630 significantly reduces the severity of symptoms, leads to a more favourable course of the disease and a faster recovery from acute bronchitis compared with the placebo, and is well tolerated.


Supplements analyzed in this study

African Geranium

Health conditions analyzed in this study

Acute Bronchitis


Highly Positive
African Geranium

Cough


Slightly Positive
African Geranium

Headache


Slightly Positive
African Geranium

Nausea and Vomiting


Slightly Positive
African Geranium


Functions related to this study

Digestion


Slightly Positive
African Geranium

Emotional health


Slightly Positive
African Geranium

Immunity


Highly Positive
African Geranium

Mental health


Slightly Positive
African Geranium

Overall health


Slightly Positive
African Geranium

Weight loss


Slightly Negative
African Geranium


Body systems related to this study


Digestive System

Nervous System

Respiratory System
Scroll to top